A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
Clinical trial NCT06554301 · RECRUITING
Trial details
- NCT number
- NCT06554301
- Sponsor
- China National Center for Cardiovascular Diseases
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-20
- Primary completion
- 2026-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.